PFM
VRTX icon

Patton Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Patton Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-526
Closed -$235K – 459
2026
Q1 		$235K Buy
+526
New +$245K 0.04% 363
2025
Q1 		– Sell
-10,084
Closed -$4.06M – 91
2024
Q4 		$4.06M Sell
10,084
-1,515
-13% -$702K 0.8% 61
2024
Q3 		$5.39M Sell
11,599
-641
-5% -$308K 1.11% 39
2024
Q2 		$5.74M Sell
12,240
-2,418
-16% -$1.05M 1.21% 24
2024
Q1 		$6.13M Buy
+14,658
New +$6.2M 1.11% 29
2023
Q4 		– Sell
-6,309
Closed -$2.19M – 99
2023
Q3 		$2.19M Sell
6,309
-4,220
-40% -$1.48M 0.59% 31
2023
Q2 		$3.71M Sell
10,529
-796
-7% -$268K 1.08% 16
2023
Q1 		$3.57M Buy
11,325
+3,933
+53% +$1.18M 1.02% 16
2022
Q4 		$2.13M Sell
7,392
-295
-4% -$89.9K 0.62% 55
2022
Q3 		$2.23M Buy
+7,687
New +$2.21M 0.9% 24
2020
Q4 		– Sell
-6,129
Closed -$1.67M – 95
2020
Q3 		$1.67M Sell
6,129
-39
-0.6% -$10.8K 0.9% 40
2020
Q2 		$1.79M Buy
+6,168
New +$1.67M 1.04% 19

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

Patton Fund Management's VRTX Position: Q2 2026 in Review

Patton Fund Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 526 shares — an estimated $235K sold.

Patton Fund Management first reported a position in VRTX in Q2 2020 and held it in 12 quarters. The position peaked at $6.13M in Q1 2024. 307 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Patton Fund Management reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 526 Vertex Pharmaceuticals shares in Q2 2026, an estimated $235K.
  • Patton Fund Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • Patton Fund Management's Vertex Pharmaceuticals position peaked at $6.13M in Q1 2024.
  • 307 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.